Literature DB >> 2025007

Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.

I Smith1, M G Beasley, A E Ades.   

Abstract

A total of 599 children with phenylketonuria, who had been treated early, were followed up prospectively in order to examine the association between intellectual progress from 4 to 14 years of age and control of phenylalanine concentrations. The phenylalanine rose from around 400 mumol/l during the first four years to above 900 mumol/l by 12 years. The children were divided into two cohorts: cohort I comprised 224 children born in the United Kingdom between 1964 and 1971 and cohort II 375 children born between 1972 and 1978. In a previous study it was shown that by 4 years of age these children already had a mean intelligence quotient (IQ) over half a standard deviation below general population norms, and that IQ fell linearly as average phenylalanine concentrations rose. Multiple regression was used to estimate the size of the associations between IQ at later ages and average phenylalanine concentrations in the periods between assessments, after controlling for previous IQ and phenylalanine control, social class, type of phenylketonuria, and factors relating to diagnosis and early management. For each 300 mumol/l rise in average phenylalanine concentrations for those aged 5 to 8 years IQ at 8 years fell by 4-6 points. This compared with a 7-10 point fall in IQ at 4 years for a similar rise in phenylalanine. After 8 years of age the association between IQ and phenylalanine control disappeared in cohort I but persisted in cohort II and was significant up to 10 years of age, although the association was smaller than at 8 years.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025007      PMCID: PMC1792859          DOI: 10.1136/adc.66.3.311

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Neuro-pathologic observations in phenylketonuria.

Authors:  C M POSER; L VAN BOGAERT
Journal:  Brain       Date:  1959-03       Impact factor: 13.501

2.  [Limitations of the classification and nomenclature of hyperphenylalaninemia].

Authors:  O Wolff; I Smith; M Beasley
Journal:  Arch Fr Pediatr       Date:  1987

3.  Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register.

Authors:  I Smith; M G Beasley; O H Wolff; A E Ades
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

4.  Termination of dietary treatment in phenylketonuria.

Authors:  B Cabalska; N Duczyńska; J Borzymowska; K Zorska; A Koślacz-Folga; K Bozkowa
Journal:  Eur J Pediatr       Date:  1977-11-04       Impact factor: 3.183

5.  Neuropathology of phenylketonuria.

Authors:  N Malamud
Journal:  J Neuropathol Exp Neurol       Date:  1966-04       Impact factor: 3.685

6.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  A new approach to the treatment of phenylketonuria.

Authors:  O E Pratt
Journal:  J Ment Defic Res       Date:  1980-09

8.  Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria.

Authors:  I Smith; M E Lobascher; J E Stevenson; O H Wolff; H Schmidt; S Grubel-Kaiser; H Bickel
Journal:  Br Med J       Date:  1978-09-09

9.  Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalaninaemia. Relevance to termination of dietary treatment in human phenylketonuria.

Authors:  F A Hommes; A G Eller; E H Taylor
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

10.  Preliminary report on the effects of diet discontinuation in PKU.

Authors:  R Koch; C G Azen; E G Friedman; M L Williamson
Journal:  J Pediatr       Date:  1982-06       Impact factor: 4.406

View more
  19 in total

1.  Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Authors:  L G Greeves; C C Patterson; D J Carson; R Thom; M C Wolfenden; J Zschocke; C A Graham; N C Nevin; E R Trimble
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

2.  Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury.

Authors:  M Dennis; L Lockyer; A L Lazenby; R E Donnelly; M Wilkinson; W Schoonheyt
Journal:  J Autism Dev Disord       Date:  1999-02

3.  Predictability and inconsistencies in the cognitive outcome of early treated PKU patients.

Authors:  Filippo Manti; Francesca Nardecchia; Sabrina Paci; Flavia Chiarotti; Claudia Carducci; Carla Carducci; Silvia Dalmazzone; Graziella Cefalo; Elisabetta Salvatici; Giuseppe Banderali; Vincenzo Leuzzi
Journal:  J Inherit Metab Dis       Date:  2017-08-23       Impact factor: 4.982

4.  MR imaging-based volumetry in patients with early-treated phenylketonuria.

Authors:  Nadine H Pfaendner; Gitta Reuner; Joachim Pietz; Gregor Jost; Dietz Rating; Vincent A Magnotta; Alexander Mohr; Bodo Kress; Klaus Sartor; Stefan Hähnel
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

5.  Phenylketonuric patients decades after diet.

Authors:  R O Fisch; P N Chang; S Weisberg; P Guldberg; F Güttler; M Y Tsai
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

6.  Intelligence in mild atypical phenylketonuria.

Authors:  P M Costello; M G Beasley; S L Tillotson; I Smith
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

7.  Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.

Authors:  F Rey; V Abadie; F Plainguet; J Rey
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

8.  Intelligence and professional career in young adults treated early for phenylketonuria.

Authors:  H Schmidt; P Burgard; J Pietz; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Phenylketonuria: treatment in adolescence and adult life.

Authors:  D P Brenton; A C Tarn; J C Cabrera-Abreu; M Lilburn
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

10.  Information processing in patients with early and continuously-treated phenylketonuria.

Authors:  B A Stemerdink; J J van der Meere; M W van der Molen; A F Kalverboer; M M Hendrikx; J Huisman; L W van der Schot; F M Slijper; F J van Spronsen; P H Verkerk
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.